Science Brief: ePRO in Oncology Clinical Trials

SCIENCE BRIEF

ePRO in Oncology Clinical Trials

Electronic Patient Reported Outcome (ePRO) is increasingly becoming an important aspect of cancer clinical trials and patient care, especially with regard to measuring drug efficacy, patient quality of life, and drug safety. Learn more about patient preference and compliance levels when using ERT eCOA Tablet and Handheld devices from this original ERT science research.


ScienceBrief_SE_eCOA_Oncology_share






Share